Sichuan Dowell Science and Technology Inc.
SZSE:300535.SZ
16.34 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 724.599 | 510.385 | 629.818 | 469.644 | 396.342 | 356.136 | 332.678 | 299.157 | 275.063 | 270.416 | 267.058 | 237.871 | 212.846 |
Cost of Revenue
| 508.639 | 366.128 | 397.464 | 290.351 | 207.318 | 185.807 | 173.12 | 147.48 | 138.105 | 144.697 | 154.621 | 142.579 | 130.888 |
Gross Profit
| 215.96 | 144.257 | 232.354 | 179.294 | 189.025 | 170.329 | 159.559 | 151.677 | 136.958 | 125.719 | 112.437 | 95.292 | 81.958 |
Gross Profit Ratio
| 0.298 | 0.283 | 0.369 | 0.382 | 0.477 | 0.478 | 0.48 | 0.507 | 0.498 | 0.465 | 0.421 | 0.401 | 0.385 |
Reseach & Development Expenses
| 42.36 | 29.797 | 42.244 | 37.471 | 39.034 | 24.3 | 20.414 | 17.4 | 16.023 | 15.13 | 14.826 | 0 | 0 |
General & Administrative Expenses
| 16.162 | 15.487 | 15.413 | 9.919 | 11.469 | 7.431 | 12.426 | 6.752 | 7.533 | 7.135 | 5.283 | 27.77 | 23.814 |
Selling & Marketing Expenses
| 27.78 | 40.769 | 42.881 | 29.755 | 54.108 | 49.291 | 40.785 | 32.8 | 30.516 | 31.78 | 28.248 | 24.682 | 17.963 |
SG&A
| 124.536 | 56.256 | 58.294 | 39.674 | 65.577 | 56.722 | 53.211 | 39.552 | 38.049 | 38.915 | 33.531 | 52.452 | 41.777 |
Other Expenses
| 37.219 | -0.013 | 0.534 | -0.09 | -0.039 | -0.038 | 2.2 | 1.548 | 1.7 | 2.505 | 2.343 | 4.917 | 0.701 |
Operating Expenses
| 204.115 | 130.565 | 152.722 | 119.208 | 142.166 | 122.497 | 102.812 | 81.748 | 73.316 | 72.991 | 65.628 | 53.894 | 43.012 |
Operating Income
| 11.846 | -12.977 | 71.133 | 57.38 | 43.176 | 48.425 | 57.785 | 66.513 | 57.571 | 43.998 | 38.745 | 34.762 | 34.127 |
Operating Income Ratio
| 0.016 | -0.025 | 0.113 | 0.122 | 0.109 | 0.136 | 0.174 | 0.222 | 0.209 | 0.163 | 0.145 | 0.146 | 0.16 |
Total Other Income Expenses Net
| -0.971 | -0.013 | 0.534 | -0.09 | -0.039 | -0.038 | 2.2 | 1.534 | -0.477 | 2.5 | 2.327 | 4.896 | 0.701 |
Income Before Tax
| 10.875 | -12.99 | 71.667 | 57.291 | 43.137 | 48.386 | 59.984 | 68.047 | 57.094 | 46.498 | 41.072 | 39.658 | 34.828 |
Income Before Tax Ratio
| 0.015 | -0.025 | 0.114 | 0.122 | 0.109 | 0.136 | 0.18 | 0.227 | 0.208 | 0.172 | 0.154 | 0.167 | 0.164 |
Income Tax Expense
| 7.322 | 4.212 | 5.979 | 1.851 | 3.845 | 7.148 | 8.238 | 10.241 | 9.111 | 6.548 | 6.828 | 7.023 | 6.276 |
Net Income
| 28.428 | -1.828 | 65.837 | 57.03 | 39.369 | 41.407 | 51.754 | 57.821 | 48.092 | 40.175 | 34.244 | 32.635 | 28.551 |
Net Income Ratio
| 0.039 | -0.004 | 0.105 | 0.121 | 0.099 | 0.116 | 0.156 | 0.193 | 0.175 | 0.149 | 0.128 | 0.137 | 0.134 |
EPS
| 0.27 | -0.018 | 0.65 | 0.57 | 0.4 | 0.42 | 0.52 | 0.7 | 0.64 | 0.54 | 0.46 | 0.44 | 0.38 |
EPS Diluted
| 0.27 | -0.018 | 0.64 | 0.56 | 0.38 | 0.4 | 0.52 | 0.7 | 0.64 | 0.54 | 0.46 | 0.44 | 0.38 |
EBITDA
| 61.401 | 27.468 | 111.29 | 87.985 | 68.101 | 59.24 | 75.627 | 81.375 | 72.716 | 62.377 | 57.284 | 41.399 | 39.825 |
EBITDA Ratio
| 0.085 | 0.081 | 0.183 | 0.203 | 0.177 | 0.193 | 0.237 | 0.282 | 0.278 | 0.246 | 0.22 | 0.177 | 0.187 |